• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Public Health . Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis

tetano

Editor, Senior Moderator
BMC Public Health


. 2021 Aug 4;21(1):1505.
doi: 10.1186/s12889-021-11546-6.
Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis


Zixin Cai[SUP] #[/SUP][SUP] 1 [/SUP], Yan Yang[SUP] #[/SUP][SUP] 1 [/SUP], Jingjing Zhang[SUP] 2 [/SUP]



Affiliations

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has led to global research to predict those who are at greatest risk of developing severe disease and mortality. The aim of this meta-analysis was to determine the associations between obesity and the severity of and mortality due to COVID-19.
Methods: We searched the PubMed, EMBASE, Cochrane Library and Web of Science databases for studies evaluating the associations of obesity with COVID-19. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using random- or fixed-effects models. Meta-regression analyses were conducted to estimate regression coefficients.
Results: Forty-six studies involving 625,153 patients were included. Compared with nonobese patients, obese patients had a significantly increased risk of infection. (OR 2.73, 95% CI 1.53-4.87; I[SUP]2[/SUP] = 96.8%), hospitalization (OR 1.72, 95% CI 1.55-1.92; I[SUP]2[/SUP] = 47.4%), clinically severe disease (OR 3.81, 95% CI 1.97-7.35; I[SUP]2[/SUP] = 57.4%), mechanical ventilation (OR 1.66, 95% CI 1.42-1.94; I[SUP]2[/SUP] = 41.3%), intensive care unit (ICU) admission (OR 2.25, 95% CI 1.55-3.27; I[SUP]2[/SUP] = 71.5%), and mortality (OR 1.61, 95% CI 1.29-2.01; I[SUP]2[/SUP] = 83.1%).
Conclusion: Patients with obesity may have a greater risk of infection, hospitalization, clinically severe disease, mechanical ventilation, ICU admission, and mortality due to COVID-19. Therefore, it is important to increase awareness of these associations with obesity in COVID-19 patients.

Keywords: COVID-19; Mortality; Obesity; Predict; Severity.
 
Back
Top Bottom